Burnham Asset Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
$749K Sell
12,097
-4,458
-27% -$272K 0.21% 88
2016
Q1
$944K Sell
16,555
-735
-4% -$41K 0.3% 83
2015
Q4
$1.02M Sell
17,290
-235
-1% -$13.5K 0.28% 79
2015
Q3
$954K Sell
17,525
-75
-0.4% -$4.88K 0.25% 86
2015
Q2
$1.18M Sell
17,600
-800
-4% -$52.2K 0.27% 87
2015
Q1
$1.08M Buy
18,400
+1,950
+12% +$118K 0.25% 95
2014
Q4
$1.08M Hold
16,450
0.24% 103
2014
Q3
$950K Sell
16,450
-200
-1% -$11.1K 0.21% 117
2014
Q2
$940K Sell
16,650
-200
-1% -$10.5K 0.21% 121
2014
Q1
$866K Sell
16,850
-100
-0.6% -$5.05K 0.21% 119
2013
Q4
$895K Sell
16,950
-200
-1% -$9.83K 0.21% 119
2013
Q3
$767K Sell
17,150
-500
-3% -$22.2K 0.19% 124
2013
Q2
$730K Buy
+17,650
New +$772K 0.19% 124

Other funds holding ABBV

Burnham Asset Management's ABBV Position: Q2 2016 in Review

Burnham Asset Management reduced its AbbVie (ABBV) stake by 27% in Q2 2016, selling an estimated $272K and leaving 12,097 shares worth $749K. The position accounts for 0.21% of the portfolio, ranked #88.

Burnham Asset Management first reported a position in ABBV in Q2 2013 and has held it in 13 quarters since. The position peaked at $1.18M in Q2 2015. 1,634 funds tracked by Wall St. Rank hold ABBV as of Q2 2016.

  • Burnham Asset Management held 12,097 shares of AbbVie worth $749K as of Q2 2016.
  • Burnham Asset Management sold 4,458 AbbVie shares in Q2 2016, an estimated $272K.
  • AbbVie made up 0.21% of Burnham Asset Management's portfolio in Q2 2016, its #88 holding.
  • Burnham Asset Management first reported a position in AbbVie in Q2 2013 and has held it in 13 quarters since.
  • Burnham Asset Management's AbbVie position peaked at $1.18M in Q2 2015.
  • 1,634 funds tracked by Wall St. Rank held AbbVie as of Q2 2016.

Based on Burnham Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.